Newphoria 2/3-FEA 35 MG/100MG Blister

€ 34,95

Newphoria 2/3-FEA Blister is a blister-format research material described as containing 2-fluoroethamphetamine (2-FEA) and 3-fluoroethamphetamine (3-FEA), two positional isomers within the fluorinated substituted amphetamine family. Raw Lab Chems presents the material exclusively for controlled chemical identification, analytical characterization, positional-isomer comparison, and reference-oriented laboratory investigation. The supplied purity and independent-testing claims require batch-specific documentation before they can be considered verified.

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

SKU: CERT-S-12743 Category:
Description

Newphoria 2/3-FEA 35mg/100mg Blister

Product Overview

Newphoria 2/3-FEA Blister is described in the supplied information as a combined research material associated with two fluorinated ethamphetamine positional isomers: 2-fluoroethamphetamine and 3-fluoroethamphetamine.

The material is presented in a blister-packaged format for controlled laboratory identification, analytical characterization, and documentation.

Raw Lab Chems identifies the product exclusively within a Research Use Only framework.

The source describes a labeled combination of two chemical components. However, the stated formulation does not independently establish the actual identity, proportion, purity, or content uniformity of the supplied material.

The scientific emphasis is on the distinction between positional isomers, analytical specificity, chemical classification, and reproducible laboratory documentation.

The source also characterizes the product as laboratory-grade and refers to third-party testing and controlled manufacturing practices.

These statements remain supplier-provided claims until supported by records associated with the actual batch.

No clinical, diagnostic, therapeutic, or consumer-oriented application is represented by this description.

Chemical Identity & Classification

The supplied product description identifies two chemical components:

  • 2-FEA: 2-Fluoroethamphetamine
  • 3-FEA: 3-Fluoroethamphetamine

Both compounds are described as synthetic fluorinated N-ethyl amphetamine derivatives within the broader substituted phenethylamine family.

Their principal structural distinction is the position of the fluorine substituent on the aromatic ring.

In 2-FEA, fluorine occupies the 2-position, while in 3-FEA, fluorine occupies the 3-position.

This positional difference is important in analytical chemistry because structurally related compounds may require sufficiently selective identification methods.

The source lists the molecular formula C11H16FN and molecular weight 181.25 g/mol for the named isomers.

It also supplies the following CAS Registry Numbers:

  • 2-FEA: 3871-89-4
  • 3-FEA: 1215748-19-8

These identifiers are reproduced as source-provided information and have not been independently verified against the supplied product.

The source does not establish the actual salt forms or complete formulation composition.

Researchers seeking public chemical-reference information may consult PubChem, taking care to match each database record to the correct positional isomer and chemical form.

Chemical & Physical Characteristics

The supplied product is described as a blister-packaged preparation containing two named fluorinated ethamphetamine derivatives.

No verified information was supplied concerning the physical appearance, crystalline form, particle size, excipients, binders, coating, or other formulation components.

The chemical similarity between the two named compounds is relevant to analytical differentiation.

However, shared molecular formula information does not establish identical chromatographic behavior, physical properties, stability, or impurity profiles.

The source recommends cool, dry storage with protection from light.

It additionally specifies a recommended storage temperature of 2–8°C.

No validated stability study, degradation profile, or experimentally established shelf-life specification accompanied this recommendation.

The stated temperature range should therefore be treated as source-provided guidance rather than independently verified stability data.

Physical and chemical characteristics relevant to a particular investigation should be established using suitable analytical documentation associated with the actual material.

Purity & Analytical Verification

The supplied source describes a purity level of at least 98% for each component, characterized as typical and third-party verified.

No batch-specific Certificate of Analysis, chromatogram, mass spectrum, NMR spectrum, or independent laboratory report accompanied the information.

Accordingly, the stated purity threshold is not independently verified for the actual preparation.

The source identifies HPLC, GC-MS, LC-MS, and NMR spectroscopy as techniques associated with analytical characterization of these compounds.

These methods may support chemical identification, structural investigation, impurity assessment, and differentiation between related compounds.

However, naming an analytical technique does not establish that it has been performed on the specific material described here.

Because the product contains two named positional isomers, analytical interpretation should distinguish the identity and reported characteristics of each component.

A combined product label is not a substitute for component-specific analytical verification.

Researchers should evaluate any available analytical findings against the exact sample, batch identifier, method limitations, reference materials, and supporting documentation.

Quality Control & Batch Integrity

The supplied description claims third-party Certificates of Analysis, independent identity verification, batch-specific traceability, and manufacturing under ISO-compliant conditions.

No actual certificate, laboratory identity, accreditation record, manufacturing audit, or batch-specific quality document was supplied.

These statements therefore remain unverified supplier claims.

The source also describes the material as suitable for analytical reference work.

However, the information provided does not establish certified reference-material status, metrological traceability, or an assigned measurement uncertainty.

For reproducible research, useful records may include the material identifier, named components, batch number, supplier, receipt date, storage history, and available analytical results.

Where component-specific purity is claimed, supporting documentation should identify the analytical basis for each reported result.

A general description of quality assurance does not independently demonstrate verified composition or uniformity.

Safety, Handling & Laboratory Precautions

2-FEA and 3-FEA are substituted amphetamine derivatives requiring appropriate institutional risk assessment and controlled laboratory handling.

Research personnel should consult applicable chemical-safety information and institutional procedures before receiving or examining the material.

Precautions should address access restrictions, protective equipment, contamination prevention, secure sample identification, accidental exposure, and waste disposal.

The supplied blister presentation must not be interpreted as evidence of pharmaceutical suitability or authorization for personal use.

The material should remain secured against unauthorized access and separated from food, beverages, and non-research environments.

Because the preparation is described as containing more than one active chemical component, risk assessment should account for the complete material rather than assuming that a single-component safety profile is sufficient.

No safety claim for human or veterinary exposure is established by the supplied product information.

Packaging, Labeling & Storage

The supplied product is identified as a blister-packaged research preparation.

The source describes secure packaging, protective labeling, and controlled handling during transportation.

No packaging-validation study, verified barrier-performance specification, or actual shipment-condition record accompanied these statements.

The supplied storage guidance recommends a cool, dry, light-protected environment and specifies 2–8°C.

This recommendation has not been independently supported by batch-specific stability documentation.

Laboratory inventory records should identify the product, its two named chemical components, any available batch number, and relevant storage observations.

Where chemical forms or analytical specifications remain unverified, records should preserve those uncertainties.

Appropriate packaging and environmental conditions should be assessed using available supplier documentation, applicable safety requirements, and relevant stability information.

Intended Research Use & Market Positioning

The supplied scientific context places Newphoria 2/3-FEA within analytical research involving fluorinated amphetamine derivatives, positional-isomer identification, chemical characterization, and comparative laboratory investigation.

The presence of two named positional isomers provides a basis for research documentation concerning chemical identity and analytical differentiation.

For comparative catalog context, Raw Lab Chems also lists 2-FEA Pellets and 2/3-FEA Pellets.

These listings describe related research-material presentations but do not independently establish equivalent purity, formulation, or analytical characteristics.

The supplied Newphoria 2/3-FEA Blister catalog reference identifies the product presentation discussed here.

These references provide chemical-catalog context rather than evidence of certified reference-material status or interchangeability.

Ordering, Availability & Fulfillment

The supplied source describes worldwide shipping, discreet packaging, tracking, and professional handling for research institutions.

No current inventory information, carrier documentation, shipment record, or destination-specific regulatory authorization accompanied these statements.

Accordingly, no specific availability, dispatch, delivery, or customs-clearance guarantee is asserted.

Fluorinated amphetamine derivatives may be regulated under controlled-substance or analog legislation.

Institutional acquisition and transfer should therefore be assessed against the applicable laws governing the exact compounds and chemical forms involved.

Researchers and institutions should independently verify whether possession, importation, exportation, transportation, and laboratory investigation are authorized in their jurisdictions.

Research-only labeling does not establish an exemption from controlled-substance regulations.

Legal & Regulatory Disclaimer

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

Newphoria 2/3-FEA is described as a combined research preparation associated with fluorinated amphetamine derivatives whose regulatory classification may vary by jurisdiction.

Acquisition, possession, transfer, importation, exportation, storage, and laboratory investigation may be restricted or prohibited under applicable controlled-substance, analog, or other chemical regulations.

Researchers and institutions remain responsible for determining legal requirements and obtaining any necessary authorizations.

No medical approval, consumer-use authorization, universal legal status, or regulatory exemption is implied by this description.

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Newphoria 2/3-FEA 35 MG/100MG Blister”
Shipping & Delivery